Clofarabine: Past, present, and future

Lotfi K, 1999, Clin Cancer Res, 5, 2438

10.1073/pnas.89.7.2970

Parker W, 1998, Mol Pharmacol, 55, 515

10.1016/0065-2571(94)90006-X

10.1016/0163-7258(95)00015-9

10.1038/nrd2055

Genini D, 2000, Blood, 96, 3537, 10.1182/blood.V96.10.3537

Xie C, 1995, Cancer Res, 55, 2847

10.1007/BF00686505

10.1177/0091270004269236

Xie K, 1996, Cancer Res, 56, 3030

Cooper T, 2005, Pharmacol, 55, 361

10.1182/blood-2006-05-023259

Warrell R P, 1986, J Clin Oncol, 4, 74, 10.1200/JCO.1986.4.1.74

10.1200/JCO.2003.04.031

10.1182/blood-2003-06-2122

10.1200/JCO.2005.03.8554

10.1182/blood-2003-03-0925

Gandhi V, 2003, Clinical Cancer Res, 9, 6335

Foran J, 2003, Proc Am Soc Clin Oncol, 22, 587

10.1182/blood-2004-05-1933

Agura E, 2006, Blood, 108, 552a, 10.1182/blood.V108.11.1951.1951

Yamauchi T, 2001, Clin Cancer Res, 7, 3580

10.1182/blood-2005-08-3294

10.1182/blood-2006-07-034660

10.1182/blood-2005-08-3294

Burnett A, 2004, Blood, 104, 869, 10.1182/blood.V104.11.869.869

Burnett A, 2006, Blood, 108, 1985, 10.1182/blood.V108.11.1985.1985

Faderl S, 2005, Blood, 106

Foran J, 2005, Blood, 106

Burnett A, 2006, Blood, 108

10.1002/cncr.21723

Burnett A, 2006, Proc Am Soc Clin Oncol, 24

Faderl S, 2005, Blood, 106

10.1200/JCO.2005.05.4346

10.1002/cncr.22508

Faderl S, 2006, Blood, 108